Delivery Order SPE2DB22D2108-SPE2DB23FU4PY
Award Date 9/29/23
Potential Completion Date 10/2/23
Potential Value $367
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Defense Logistics Agency awarded a $328 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for ACAMPROSATE CALC DR 333 MG TAB 180S. The order was issued on October 12, 2023 to be completed by October 13, 2023. The place of performance is Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. The Defense Logistics Agency manages the global supply chain for the United States military and supports...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.52 to AmerisourceBergen Drug Corp for the supply of Acamprosate Calcium 333 mg tablets (180-count) with a completion deadline of September 12, 2025. This is a firm fixed price, non-competitive delivery order issued under a child contract arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs...
- The Defense Logistics Agency awarded a delivery order valued at $2,129.04 to AmerisourceBergen Drug Corp for 180 tablets of Acamprosate Calcium 333 mg, with an ultimate completion date of September 15, 2025. This non-competitive, firm fixed-price delivery order was issued on September 13, 2025, with performance to take place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $302,610 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4561306723 ACAMPROSATE CALC DR 333 MG TAB 180S. As the prime contractor, Amerisourcebergen will deliver the specified pharmaceutical products from its facility in Conshohocken, Pennsylvania to the Defense Logistics Agency by June 21, 2023 to support the agency's medical supply needs. The award was made using the DLA's indefinite-delivery/indefinite-quantity...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX6WP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,755.18 firm fixed-price delivery order is for the supply of 180 tablets of Acamprosate Calcium delayed-release 333 mg. The contract has a completion date of December 12, 2023 and was awarded on December 11, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,778.22 by the Defense Logistics Agency (DLA) on October 20, 2025, for the supply of Attruby 356 mg tablets (28-count packages). This firm fixed-price delivery order, with an ultimate completion date of November 10, 2025, represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a $71,400 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 count bottles of acetaminophen tablets. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by September 8, 2023 in support of the Defense Logistics Agency's medical supply needs. No set aside designation or subcontractors were identified for this delivery order placed...
- The Defense Logistics Agency awarded a $683,950 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561312185 unit capsules. The one-day contract has a period of performance from June 20, 2023 through June 21, 2023 for the delivery of pharmaceutical products. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania to support the Defense Logistics Agency's supply chain management and distribution activities. No subcontractors or...
- Amerisourcebergen Drug Corp has been awarded a delivery order against an undisclosed government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical. The firm fixed price order, valued at six hundred thirty-three dollars, is for the delivery of sixty capsules of acetazolamide extended release 500 mg to an address in Conshohocken, Pennsylvania. The order has no set-aside designation and is required to be completed by October 23, 2023. As the Defense Logistics Agency...
- This delivery order against an unidentified contract vehicle was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp on October 12, 2023, for the delivery of one hundred amphetamine tablets to Conshohocken, Pennsylvania. The firm fixed price value of this order is one hundred twenty-three dollars. Performance is to be completed by October 13, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, located in Conshohocken. No set-aside designation...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB23FU4PYDelivery Order
Defense Logistics Agency awarded a $366 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the acquisition of 180 tablets of ACAMPROSATE CALC DR 333 MG each, with performance at the contractor's facility in Conshohocken, Pennsylvania and no set-aside designation used. The delivery order was issued under an existing vehicle and has an anticipated completion date of October 2, 2023 to supply the agency with the specified pharmaceutical product.
Generated 1/3/24, 2:36 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $367 | 9/29/23 |